Lauren Feldman 2/09/2024 at 4:23 pm
One Green Planet (February 9, 2024) FDA Modernization Act 3.0 Introduced to Reform Animal Testing
A bipartisan group of lawmakers in the House introduced the FDA Modernization Act 3.0 on February 6, 2024. The bill aims to push the U.S. Food and Drug Administration (FDA) to implement the FDA Modernization Act 2.0, a law passed in the 117th Congress. The proposed legislation, FDA Modernization Act 3.0, mandates the FDA to finalize rules for implementing FDAMA 2.0. It seeks to establish clear guidelines for non-animal test methods that better predict drug safety and efficacy. By doing so, the bill aims to expedite the time to market for new treatments and cures, benefiting both patients and drug sponsors.
Genetic Engineering & Biotechnology News (February 9, 2024) Scenes from SLAS: AI, Organs-on-Chips Resonate at Record Lab Automation Show
A record attendance of 7,549 scientists, pharma executives, and vendors left Boston this week feeling positive about the event and the state of the industry more broadly. AI, organoids, and organs-on-chips were three of the prominent themes evident throughout the conference program and the trade show exhibition, as the Society of Lab Automation and Screening (SLAS) 2024 organizers had promised GEN in a preview last week.
National Institute of Standards and Technology (February 6, 2024) NIST’s Heart-on-a-Chip: A Microfluidic Marvel Shaping the Future of Cardiovascular Research
In a major step forward in drug development, researchers at the National Institute of Standards and Technology (NIST) have developed a tool for building a system known as heart-on-a-chip (HoC). This technology seeks to address the limitations of conventional cardiovascular drug development, which relies heavily on animal testing. By replicating humanlike models for studying cardiovascular diseases, the HoC system holds the promise of helping to replace animal testing, shortening drug development timelines and reducing costs. The NIST team’s results were published in Lab on a Chip.
Medriva (February 6, 2024) The Revolutionary Heart-on-a-Chip Technology: A Giant Leap in Drug Development
In the quest to revolutionize drug development, researchers at the National Institute of Standards and Technology (NIST) have made a groundbreaking advancement with the development of a heart-on-a-chip (HoC) system. This innovative technology aims to replace animal testing, significantly reduce drug development timelines, and cut costs, marking a significant step towards a future characterized by precision, efficiency, and heightened ethical considerations in drug development.
- You must be logged in to reply to this topic.